Stephen M. Miley, MD, has resigned as CEO of Axcess Medical Imaging, and the company and its subsidiaries have filed for Chapter 11 bankruptcy.

Abbott has expanded its XIENCE V USA post-approval study designed to evaluate the safety and effectiveness of its Xience V everolimus-eluting coronary stent in a real-world clinical setting out to five years. The expansion allows for more than 2,000 patients from the XIENCE V trial to cross over into the Dual Anti-Platelet Therapy (DAPT) trial.

Uterine fibroid embolization is highlighted as an appropriate treatment for women in a clinical therapeutics article in the Aug. 13 issue of the New England Journal of Medicine.

Two University of Arizona researchers have formed a research team to design, build and evaluate two versions of an ovarian cancer medical imaging and screening instrument that will use holographic components in a new type of optical microscope.

The challenges of todays healthcare economic climate are such that practices can no longer afford to conduct business in the same manner as they have in the past. One of the ways in which a radiology group can meet these challenges is to tune its digital workflow for maximum efficiency.

Using MRI before surgery to assess the extent of early breast cancer has not been shown to improve surgical planning, reduce follow-up surgery or reduce the risk of local recurrences. A review, appearing Aug. 13 online in CA: A Cancer Journal for Clinicians, says evidence shows that MRI utilization increases the chances of more extensive surgery over conservative approaches, with no evidence that it improves surgical care or prognosis.

InVivo has introduced an MR prostate solution for analysis, planning and interventional biopsy.

Emory University in Atlanta has been a major beneficiary of funding from the National Institutes of Health (NIH) through the American Recovery and Reinvestment Act (ARRA) of 2009.